DEF 14A

Company

Crinetics Pharmaceuticals, Inc.

Filed

April 30, 2021

Period of Report

June 22, 2021

Accession Number

0001564590-21-022087

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →